Back to top
more

The Pennant Group (PNTG)

(Real Time Quote from BATS)

$23.00 USD

23.00
56,097

+0.59 (2.63%)

Updated May 17, 2024 12:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (47 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

PNTG vs. CHE: Which Stock Is the Better Value Option?

by Zacks Equity Research

PNTG vs. CHE: Which Stock Is the Better Value Option?

The Pennant Group, Inc. (PNTG) Matches Q4 Earnings Estimates

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 0% and 6.01%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Encompass Health (EHC) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Encompass Health (EHC) delivered earnings and revenue surprises of 3.53% and 1.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Industry Outlook Highlights Option Care Health, LifeStance Health, Addus HomeCare and Pennant

by Zacks Equity Research

Option Care Health, LifeStance Health, Addus HomeCare and Pennant have been highlighted in this Industry Outlook article.

4 Stocks to Watch Amid a Challenging Outpatient Home Health Industry

by Zacks Equity Research

Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. OPCH, LFST, ADUS and PNTG are well poised to gain from the prospects.

PNTG or CHE: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PNTG vs. CHE: Which Stock Is the Better Value Option?

Are Investors Undervaluing The Pennant Group (PNTG) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

PNTG vs. CHE: Which Stock Is the Better Value Option?

by Zacks Equity Research

PNTG vs. CHE: Which Stock Is the Better Value Option?

The Pennant Group, Inc. (PNTG) Q3 Earnings Lag Estimates

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of -22.22% and 2.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

PNTG vs. CHE: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PNTG vs. CHE: Which Stock Is the Better Value Option?

Wall Street Analysts Believe The Pennant Group, Inc. (PNTG) Could Rally 44%: Here's is How to Trade

by Zacks Equity Research

The consensus price target hints at a 43.5% upside potential for The Pennant Group, Inc. (PNTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The Pennant Group, Inc. (PNTG) Meets Q2 Earnings Estimates

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 0% and 2.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Addus HomeCare (ADUS) Q2 Earnings Surpass Estimates

by Zacks Equity Research

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 1.11% and 1.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

The Pennant Group, Inc. (PNTG) Stock Jumps 6%: Will It Continue to Soar?

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Is the Options Market Predicting a Spike in The Pennant Group (PNTG) Stock?

by Zacks Equity Research

Investors need to pay close attention to The Pennant Group (PNTG) stock based on the movements in the options market lately.

Why The Pennant Group, Inc. (PNTG) Might be Well Poised for a Surge

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Does The Pennant Group, Inc. (PNTG) Have the Potential to Rally 29% as Wall Street Analysts Expect?

by Zacks Equity Research

The consensus price target hints at a 29.4% upside potential for The Pennant Group, Inc. (PNTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The Pennant Group, Inc. (PNTG) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 37.50% and 4.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Oak Street Health, Inc. (OSH) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Oak Street Health, Inc. (OSH) delivered earnings and revenue surprises of -10.26% and 1.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Addus HomeCare (ADUS) Tops Q1 Earnings Estimates

by Zacks Equity Research

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 1.32% and 0.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Encompass Health (EHC) to Spin Off Home Health & Hospice Unit

by Zacks Equity Research

Encompass Health (EHC) expects the Enhabit Home Health & Hospice spinoff to be completed in first-half 2022.

The Pennant Group, Inc. (PNTG) Matches Q3 Earnings Estimates

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 0.00% and 0.78%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

The Pennant Group, Inc. (PNTG) to Report Q3 Results: Wall Street Expects Earnings Growth

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Pennant Group, Inc. (PNTG) Misses Q2 Earnings Estimates

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of -10.53% and 2.65%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate The Pennant Group, Inc. (PNTG) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.